AbbVie (ABBV) director Roxanne Austin granted 1,118 RSUs under incentive plan

Rhea-AI Filing Summary

AbbVie Inc. director Roxanne S. Austin received an award of 1,118 shares of common stock as a grant under the AbbVie Amended and Restated 2013 Incentive Stock Program. Following this compensation-related acquisition, she beneficially owns 39,576 AbbVie common shares directly.

According to the award terms, these are restricted stock units that will be paid on a one-to-one basis in AbbVie common shares upon the earlier of her separation from service, death, or a change in control as defined in the program.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider AUSTIN ROXANNE S

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.01 par value	1,118	$0.00	--

Holdings After Transaction: Common Stock, $0.01 par value — 39,576 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 1,118 shares Price per share for grant: $0.0000 per share Shares owned after transaction: 39,576 shares

3 metrics

RSUs granted 1,118 shares Restricted stock units awarded on 2026-05-08

Price per share for grant $0.0000 per share Compensation award, not open-market purchase

Shares owned after transaction 39,576 shares Total AbbVie common shares beneficially owned directly

Key Terms

restricted stock units, AbbVie Amended and Restated 2013 Incentive Stock Program, change in control

3 terms

restricted stock units financial

"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AbbVie Amended and Restated 2013 Incentive Stock Program financial

"awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program")"

change in control financial

"on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AUSTIN ROXANNE S

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	05/08/2026		A		1,118(1)	A	$0	39,576	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

	/s/ T.O. Odutayo, Attorney-in-Fact for Roxanne S. Austin	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AbbVie (ABBV) report for Roxanne S. Austin?

AbbVie reported that director Roxanne S. Austin received a grant of 1,118 restricted stock units under its 2013 Incentive Stock Program, increasing her direct beneficial ownership to 39,576 AbbVie common shares as reflected in this Form 4 filing.

How many AbbVie (ABBV) shares does Roxanne S. Austin hold after this grant?

After the grant, Roxanne S. Austin beneficially owns 39,576 AbbVie common shares directly. This total includes the 1,118-share award reported in the Form 4 and represents her position immediately following the compensation-related acquisition disclosed.

What type of equity award did AbbVie (ABBV) grant to Roxanne S. Austin?

Roxanne S. Austin received restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program. Each unit will be paid in one AbbVie common share upon specified events, making this a compensation grant rather than an open-market stock purchase.

When will Roxanne S. Austin’s AbbVie (ABBV) restricted stock units be paid out?

The restricted stock units will be paid in AbbVie common shares on the earlier of her separation from service, her death, or a change in control, as defined in AbbVie’s Amended and Restated 2013 Incentive Stock Program governing these awards.

Is the AbbVie (ABBV) Form 4 transaction a stock purchase or a compensation award?

The Form 4 reflects a compensation award, not a market purchase. Roxanne S. Austin acquired 1,118 restricted stock units at no cash cost as a grant under AbbVie’s 2013 Incentive Stock Program, which will convert into common shares upon specified future events.